Sanofi SA (SAN) - Total Assets

Latest as of December 2025: €126.81 Billion EUR ≈ $148.25 Billion USD

Based on the latest financial reports, Sanofi SA (SAN) holds total assets worth €126.81 Billion EUR (≈ $148.25 Billion USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check Sanofi SA total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.

Sanofi SA - Total Assets Trend (1999–2025)

This chart illustrates how Sanofi SA's total assets have evolved over time, based on quarterly financial data. Explore Sanofi SA (SAN) long-term investment share to see how much of total assets are deployed in long-term investments.

Sanofi SA - Asset Composition Analysis

Current Asset Composition (December 2025)

Sanofi SA's total assets of €126.81 Billion consist of 24.4% current assets and 75.6% non-current assets.

Asset Category	Amount (EUR)	% of Total Assets
Cash & Equivalents	€6.78 Billion	6.0%
Accounts Receivable	€397.00 Million	0.3%
Inventory	€10.21 Billion	8.1%
Property, Plant & Equipment	€11.51 Billion	9.1%
Intangible Assets	€26.26 Billion	20.7%
Goodwill	€67.56 Billion	53.3%

Asset Composition Trend (1999–2025)

This chart illustrates how Sanofi SA's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Sanofi SA (SAN) total market value.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Sanofi SA's current assets represent 24.4% of total assets in 2025, a decrease from 68.0% in 1999.
Cash Position: Cash and equivalents constituted 6.0% of total assets in 2025, up from 3.0% in 1999.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 73.0% of total assets, an increase from 3.0% in 1999.
Asset Diversification: The largest asset category is goodwill at 53.3% of total assets.

Sanofi SA Competitors by Total Assets

Key competitors of Sanofi SA based on total assets are shown below.

Company	Country	Total Assets
AstraZeneca PLC MX:AZNN	Mexico	MX$114.07 Billion
Novartis AG MX:NVSN	Mexico	MX$118.53 Billion
Biogen Inc NASDAQ:BIIB	USA	$29.44 Billion
AstraZeneca PLC F:ZEGA	Germany	€114.46 Billion
Virbac SA PA:VIRP	France	€1.82 Billion
Chongqing Lummy Pharmaceutical SHE:300006	China	CN¥2.76 Billion
Hangzhou Minsheng Healthcare Co Ltd SHE:301507	China	CN¥2.09 Billion
Firebrick Pharma Ltd AU:FRE	Australia	AU$2.28 Million

Sanofi SA - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	1.09	1.46	1.75
Quick Ratio	0.73	1.14	0.79
Cash Ratio	0.27	0.26	0.00
Working Capital	€2.61 Billion	€13.43 Billion	€14.51 Billion

Sanofi SA - Advanced Valuation Insights

This section examines the relationship between Sanofi SA's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	1.31
Latest Market Cap to Assets Ratio	0.75
Asset Growth Rate (YoY)	-4.5%
Total Assets	€126.81 Billion
Market Capitalization	$95.70 Billion USD

Valuation Analysis

Below Book Valuation: The market values Sanofi SA's assets below their book value (0.75x), which may indicate investor concerns about asset quality or future growth.

Slight Asset Contraction: Sanofi SA's assets decreased by 4.5% over the past year, which may reflect streamlining or optimization of resources.

Annual Total Assets for Sanofi SA (1999–2025)

The table below shows the annual total assets of Sanofi SA from 1999 to 2025.

Year	Total Assets	Change
2025-12-31	€126.81 Billion ≈ $148.25 Billion	-4.51%
2024-12-31	€132.80 Billion ≈ $155.25 Billion	+5.01%
2023-12-31	€126.46 Billion ≈ $147.85 Billion	+1.51%
2022-12-31	€124.58 Billion ≈ $145.65 Billion	+3.61%
2021-12-31	€120.24 Billion ≈ $140.58 Billion	+4.99%
2020-12-31	€114.53 Billion ≈ $133.90 Billion	+1.59%
2019-12-31	€112.74 Billion ≈ $131.80 Billion	+1.19%
2018-12-31	€111.41 Billion ≈ $130.25 Billion	+11.62%
2017-12-31	€99.81 Billion ≈ $116.69 Billion	-4.64%
2016-12-31	€104.67 Billion ≈ $122.37 Billion	+2.30%
2015-12-31	€102.32 Billion ≈ $119.62 Billion	+5.06%
2014-12-31	€97.39 Billion ≈ $113.86 Billion	+1.39%
2013-12-31	€96.06 Billion ≈ $112.30 Billion	-4.34%
2012-12-31	€100.41 Billion ≈ $117.39 Billion	-0.26%
2011-12-31	€100.67 Billion ≈ $117.69 Billion	+18.07%
2010-12-31	€85.26 Billion ≈ $99.68 Billion	+6.51%
2009-12-31	€80.05 Billion ≈ $93.59 Billion	+11.20%
2008-12-31	€71.99 Billion ≈ $84.16 Billion	+4.33%
2007-12-31	€69.00 Billion ≈ $80.67 Billion	-7.09%
2006-12-31	€74.27 Billion ≈ $86.83 Billion	-14.58%
2005-12-31	€86.94 Billion ≈ $101.65 Billion	+1.80%
2004-12-31	€85.41 Billion ≈ $99.85 Billion	+777.62%
2003-12-31	€9.73 Billion ≈ $11.38 Billion	+2.79%
2002-12-31	€9.47 Billion ≈ $11.07 Billion	-5.01%
2001-12-31	€9.97 Billion ≈ $11.65 Billion	+27.05%
2000-12-31	€7.84 Billion ≈ $9.17 Billion	+14.96%
1999-12-31	€6.82 Billion ≈ $7.98 Billion	--

About Sanofi SA

PA:SAN France Drug Manufacturers - General

Market Cap

$103.80 Billion

€88.79 Billion EUR

Market Cap Rank

#266 Global

#10 in France

Share Price

€73.52

Change (1 day)

+0.14%

52-Week Range

€72.72 - €90.44

All Time High

€109.62